Literature DB >> 10975015

Maternal rubella-specific antibody prevalence in Ethiopian infants.

S Kebede1, D J Nokes, F T Cutts, W Nigatu, F Sanderson, H Beyene.   

Abstract

In countries with a high transmission rate of rubella the optimal age for universal rubella vaccination of infants is critically dependent upon the rate of loss of maternal antibodies. Few studies have investigated the decay characteristics of such antibodies. Mother:infant pairs were recruited at the Ethio-Swedish Children's Hospital, Addis Ababa, in 1994/95. Rubella antibody levels, determined by radial haemolysis, were available for analysis from 1542 infants aged 0-12 months, with 942 repeat measures, and from 846 mothers. Decay in seropositivity was well described by a delayed exponential function. The proportion seropositive at age 6, 9, or 12 months was 6-13%, 1-4%, or 0-1%, respectively, dependent upon assay cutoff level. Only infant age and mother's antibody level were important predictors of seropositivity. Results suggest that the success of vaccination at age 9 months or above would be little affected by residual maternal antibodies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975015     DOI: 10.1016/s0035-9203(00)90347-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

1.  Leveraging a national biorepository in Zambia to assess measles and rubella immunity gaps across age and space.

Authors:  Andrea C Carcelen; Amy K Winter; William J Moss; Innocent Chilumba; Irene Mutale; Gershom Chongwe; Mwaka Monze; Gina Mulundu; Hope Nkamba; Francis D Mwansa; Lloyd Mulenga; Dale A Rhoda; Kyla Hayford; Simon Mutembo
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

2.  Development of serum antibodies during early infancy in rhesus macaques: implications for humoral immune responses to vaccination at birth.

Authors:  Ronald S Veazey; Chanjuan Shen; Huanbin Xu; David Liu; Xiaolei Wang
Journal:  Vaccine       Date:  2014-08-01       Impact factor: 3.641

3.  Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.

Authors:  Sandra Waaijenborg; Susan J M Hahné; Liesbeth Mollema; Gaby P Smits; Guy A M Berbers; Fiona R M van der Klis; Hester E de Melker; Jacco Wallinga
Journal:  J Infect Dis       Date:  2013-05-08       Impact factor: 5.226

4.  Rubella sero-prevalence among children in Kilimanjaro region: a community based study prior to the introduction of rubella vaccine in Tanzania.

Authors:  Nikolas A S Chotta; Melina Mgongo; Jacqueline G Uriyo; Sia E Msuya; Babill Stray-Pedersen; Arne Stray-Pedersen
Journal:  Ital J Pediatr       Date:  2017-07-21       Impact factor: 2.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.